88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

Everest Medicines Announces Interim Results for First Half of 2026 SHANGHAI , Aug. 19, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma Two head-to-head phase III trials demonstrated superior efficacy, including overall survival versus a daratumumab-based triplet in DREAMM-7 Blenrep, a first-in-class anti-BCMA ADC, could transform treatment ... 2026-08-19T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit SHANGHAI and HONG KONG , Aug. 19, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CARsgen Therapeutics Announces 2026 Interim Results SHANGHAI , Aug. 19, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2026 Interim Re ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited Yapan Bio Private Limited specializes in process development, characterization, and phase I and II GMP manufacturing services for vaccines and biologics. Piramal has held a stake in Yapan Bio since ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles Adjusted net profit surges 203.3% as Gene-to-Protein generates two-thirds of GenScript Life Science Group revenue ... 2026-08-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence SINGAPORE , Aug. 18, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused ... 2026-08-18T Biotechnology Medical/Pharmaceuticals
Enginprime Medical Closes $12M Series A Financing Round exclusively led by Qiming Venture Partners; proceeds to fund China registration trial and overseas early-stage clinical development ... 2026-08-18T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren's Contracture - All 56 planned participants enrolled approximately five months after first patient dosing ... 2026-08-17T Health Care/Hospital Medical/Pharmaceuticals
U.S. Recruitment for Ohio State University Study Evaluating EmeTerm in Adults With Chronic Nausea and Vomiting VANCOUVER, BC , Aug. 17, 2026 /PRNewswire/ -- Participant recruitment information for a clinical study being conducted at The Ohio State University has been publicly posted on ClinicalTrials.gov. The ... 2026-08-17T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved